GAINESVILLE, Fla., Dec. 16, 2025 /PRNewswire/ — Advita Ortho, a global medical technology leader, has been awarded the Innovation award in the 2025 Medical DeviceGAINESVILLE, Fla., Dec. 16, 2025 /PRNewswire/ — Advita Ortho, a global medical technology leader, has been awarded the Innovation award in the 2025 Medical Device

Advita Ortho Wins Innovation Award for Soft Tissue Balancing in Knee Replacement Surgery

GAINESVILLE, Fla., Dec. 16, 2025 /PRNewswire/ — Advita Ortho, a global medical technology leader, has been awarded the Innovation award in the 2025 Medical Device Network Excellence Awards for its Newton® Balancing Technology for total knee replacement surgery.

“We are thrilled to be recognized for our Newton Balancing Technology, which represents Advita Ortho’s commitment to patient-centered innovation,” said Aurelio Sahagun, CEO of Advita Ortho. “By transforming the technologies surgeons use to approach soft tissue management, we’re helping make knee replacement outcomes more predictable and more reliable for patients everywhere. This award validates the hard work of our team and sets the tone for the next chapter of Advita Ortho, delivering intelligent solutions that empower surgeons and advance lives.”

Newton provides ligament-driven balance by combining a force-controlled intra-articular tensioner with GPS, a platform that provides dynamic soft tissue analytics, pre-resection insights and full-range personalized planning. This streamlined technique helps surgeons reliably execute their surgical planning,1 transforming a traditionally subjective step into a data-driven, reproducible process.

At the core of Newton’s innovation is its ability to measure real-time ligament laxity under controlled tension. By applying a controlled force across the knee’s full arc of motion, the technology isolates ligament behavior, reducing variability that can occur with manual methods.2 Integrated with the company’s GPS, real-time gaps are displayed, empowering surgeons to make informed decisions about implant size, alignment, placement and soft tissue balance. 

The award also reflects the depth of evidence behind Newton’s performance. More than 50 publications and scientific presentations have shown the system’s advantages over conventional methods, including greater accuracy, higher reliability irrespective of surgeon experience and improved gap balancing.3-5

Recent peer-reviewed publications include:

  • A cadaveric study published in the Journal of Experimental Orthopaedics showed that Newton’s technique provided higher reliability and reproducibility than manual techniques.2
  • Studies published in the Journal of Orthopaedics and The Journal of Arthroplasty demonstrated significant improvements of the patient-reported outcome measures when transitioning to Newton.5-7

Newton’s goal of bringing consistency to soft-tissue management is meant to help surgeons address a leading driver of patient dissatisfaction, which has historically affected up to 20% of knee replacements.8

Backed by five granted patents, Newton lays the groundwork for future AI-powered workflows that extend beyond knee arthroplasty. The system’s compact, ASC-friendly design delivers these capabilities without the capital investment or annual maintenance burden associated with competing robotic platforms. The radiation-free technology aims to bridge the gap between data-rich planning and precise intraoperative execution.

For more information about Newton, visit www.advita.com/AI. 

References:

  1. Fan W et al. Gap Balancing Throughout the Arc of Motion with Navigated TKA and a Novel Force-Controlled Distractor: A Review of the First 273 Cases. The Journal of Arthroplasty. 2023.
  2. Casson F et al. Navigated Instrumentation and Ligament Tensioning Device Enhances Initial Gap Acquisition During Total Knee Arthroplasty Procedure: A Cadaveric Study. Journal of Experimental Orthopaedics. 2025.
  3. Dai Y et al. Multilevel Modeling of Resection Accuracy: Insights From 10,144 Clinical Cases Using a Contemporary Computer-Assisted Total Knee Arthroplasty System. Presented at the 19th Annual Meeting of the International Society for Computer Assisted Orthopaedic Surgery, Vol 3, Pages 98-101.
  4. Angibaud L et al. Ability to Achieve Mediolateral Gap Balance with Instrumented Navigated Total Knee Arthroplasty – A Review of the First 150 Cases. CAOS 2022.
  5. Chinimilli P et al. Impact of the Surgical Workflow and Technology Change on Early Clinical Outcomes in Total Knee Arthroplasty. Journal of Orthopaedics, 71, 32–39. 2025.
  6. Valtalen RS et al. Improved Clinical Outcomes with Dynamic, Force-Controlled, Gap-Balancing in Posterior-Stabilized Total Knee Arthroplasty. The Journal of Arthroplasty. 2024.
  7. Watanabe et al. Impact of Soft-Tissue Management Technique On Functional Alignment in Total Knee Arthroplasty Among Japanese Population with Severe Varus Deformity. Journal of Orthopaedics. 2025.
  8. Gunaratne R et al. Patient Dissatisfaction Following Total Knee Arthroplasty: A Systematic Review of the Literature. J Arthroplasty. 2017.

The Newton tensioner is manufactured by Exactech Inc. and distributed by Advita Ortho, LLC. GPS is manufactured by Blue Ortho SAS, an Advita Ortho subsidiary, and distributed by Advita Ortho, LLC.

About Advita Ortho
Advita Ortho is a global medical device company committed to advancing patients’ lives through innovative orthopedic solutions. We specialize in high-quality implants and a comprehensive suite of integrated surgical technologies that are powered by data, artificial intelligence and machine learning. Offering trusted leadership and clinical expertise, Advita Ortho is uniquely positioned to advance mobility and improve lives worldwide. Learn more at www.advita.com and connect with us on LinkedIn, X and Instagram.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/advita-ortho-wins-innovation-award-for-soft-tissue-balancing-in-knee-replacement-surgery-302643799.html

SOURCE Advita Ortho, LLC

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Born Again’ Season 3 Way Before Season 2

Born Again’ Season 3 Way Before Season 2

The post Born Again’ Season 3 Way Before Season 2 appeared on BitcoinEthereumNews.com. Daredevil Born Again Marvel MCU fans were thrilled that Charlie Cox’s Daredevil was being brought back to life after his unceremonious execution after his show’s Netflix run, where everything was transitioning to Disney Plus. Born Again felt like a moment that would never come, and when it did, it mostly satisfied fans, with few exceptions. Now, according to a new IGN interview with head of TV Brad Winderbaum, Marvel has greenlit Daredevil: Born Again for season 3, well before season 2 airs in March 2026. Originally, the plan was an 18-episode run across two seasons, but Marvel seems to have much larger plans for Matt Murdoch and his series. This is a combination of two things. First, the positive fan reception to season 1. While there were some hiccups here, where the middle of the season had parts of the previously canned version of the show they had to work around, the first and last few episodes were incredible, and that’s the team making all of season 2 and presumably season 3 going forward. So, that’s great news. Second, this is a move by Marvel to reduce the cost of its endless supply of Disney Plus shows by focusing on more “street level” content. MCU series have been all over the place in terms of their focus and their budgets, culminating in the ridiculous $212 million budget for six episodes of the VFX-heavy Secret Invasion, one of the worst things Marvel has ever produced. Now? The name of the game is lower costs. Agatha All Along was a prime example of this, one of the MCU’s cheapest projects ever but one of its best shows. Disney is investing deeper into the “Daredevil-verse” here, as season 2 of Born Again features Jessica Jones, who might be destined to return for her…
Share
BitcoinEthereumNews2025/09/19 02:29
Unleashing A New Era Of Seller Empowerment

Unleashing A New Era Of Seller Empowerment

The post Unleashing A New Era Of Seller Empowerment appeared on BitcoinEthereumNews.com. Amazon AI Agent: Unleashing A New Era Of Seller Empowerment Skip to content Home AI News Amazon AI Agent: Unleashing a New Era of Seller Empowerment Source: https://bitcoinworld.co.in/amazon-ai-seller-tools/
Share
BitcoinEthereumNews2025/09/18 00:10
CME Group to launch Solana and XRP futures options in October

CME Group to launch Solana and XRP futures options in October

The post CME Group to launch Solana and XRP futures options in October appeared on BitcoinEthereumNews.com. CME Group is preparing to launch options on SOL and XRP futures next month, giving traders new ways to manage exposure to the two assets.  The contracts are set to go live on October 13, pending regulatory approval, and will come in both standard and micro sizes with expiries offered daily, monthly and quarterly. The new listings mark a major step for CME, which first brought bitcoin futures to market in 2017 and added ether contracts in 2021. Solana and XRP futures have quickly gained traction since their debut earlier this year. CME says more than 540,000 Solana contracts (worth about $22.3 billion), and 370,000 XRP contracts (worth $16.2 billion), have already been traded. Both products hit record trading activity and open interest in August. Market makers including Cumberland and FalconX plan to support the new contracts, arguing that institutional investors want hedging tools beyond bitcoin and ether. CME’s move also highlights the growing demand for regulated ways to access a broader set of digital assets. The launch, which still needs the green light from regulators, follows the end of XRP’s years-long legal fight with the US Securities and Exchange Commission. A federal court ruling in 2023 found that institutional sales of XRP violated securities laws, but programmatic exchange sales did not. The case officially closed in August 2025 after Ripple agreed to pay a $125 million fine, removing one of the biggest uncertainties hanging over the token. This is a developing story. This article was generated with the assistance of AI and reviewed by editor Jeffrey Albus before publication. Get the news in your inbox. Explore Blockworks newsletters: Source: https://blockworks.co/news/cme-group-solana-xrp-futures
Share
BitcoinEthereumNews2025/09/17 23:55